Editor's Note: Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details